[
  {
    "ts": "2026-02-05T00:00:00+00:00",
    "headline": "Amazon earnings, Fed commentary, mortgage rates: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Thursday, February 5, including earnings results from companies like Amazon (AMZN), Strategy (MSTR), Shell (SHEL), and ConocoPhillips (COP); commentary from Federal Reserve Bank of Atlanta President Raphael Bostic; and the latest reading on US mortgage rates. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amazon-earnings-fed-commentary-mortgage-000000507.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "6c52d518-186f-3679-b4b3-950c7dd2109e",
      "content": {
        "id": "6c52d518-186f-3679-b4b3-950c7dd2109e",
        "contentType": "VIDEO",
        "title": "Amazon earnings, Fed commentary, mortgage rates: What to Watch",
        "description": "<p>Market Domination Overtime Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come tomorrow, Thursday, February 5, including earnings results from companies like Amazon (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/AMZN\">AMZN</a>), Strategy (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/MSTR\">MSTR</a>), Shell (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/SHEL\">SHEL</a>), and ConocoPhillips (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/COP\">COP</a>); commentary from Federal Reserve Bank of Atlanta President Raphael Bostic; and the latest reading on US mortgage rates.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Thursday, February 5, including earnings results from companies like Amazon (AMZN), Strategy (MSTR), Shell (SHEL), and ConocoPhillips (COP); commentary from Federal Reserve Bank of Atlanta President Raphael Bostic; and the latest reading on US mortgage rates. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2026-02-05T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/20ccb290-01f4-11f1-ac7f-afc2136f88e9",
          "originalWidth": 4096,
          "originalHeight": 2304,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/64AWZpDFkVsz1KJ_zzIGkg--~B/aD0yMzA0O3c9NDA5NjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/20ccb290-01f4-11f1-ac7f-afc2136f88e9.cf.webp",
              "width": 4096,
              "height": 2304,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lG_SMEjPLlKpXjfQdHMGRQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/20ccb290-01f4-11f1-ac7f-afc2136f88e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amazon-earnings-fed-commentary-mortgage-000000507.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amazon-earnings-fed-commentary-mortgage-000000507.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "COP"
            },
            {
              "symbol": "RYDAF"
            },
            {
              "symbol": "SHEL"
            },
            {
              "symbol": "CI"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "STRC"
            },
            {
              "symbol": "STRD"
            },
            {
              "symbol": "STRF"
            },
            {
              "symbol": "STRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:00:00+00:00",
    "headline": "Cell and Gene Therapy in Numbers: $1.2B in Zolgensma Sales, $1.5B Yescarta Revenue, 46 FDA-Approved Therapies and $2B Strategic Deals",
    "summary": "This report provides an in-depth analysis of the Cell and Gene Therapy industry, highlighting key company revenues, regulatory approvals, and market trends. It has been compiled by Towards Healthcare, a sister firm of Precedence Research, offering valuable insights into the latest developments and financials in this rapidly advancing field.Ottawa, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cell and gene therapy (CGT) is rapidly advancing, with major players like Novartis, Gilead, and Bristol Myers Squibb",
    "url": "https://finance.yahoo.com/news/cell-gene-therapy-numbers-1-130000843.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d5984552-e132-3083-92f2-3c08de3750a2",
      "content": {
        "id": "d5984552-e132-3083-92f2-3c08de3750a2",
        "contentType": "STORY",
        "title": "Cell and Gene Therapy in Numbers: $1.2B in Zolgensma Sales, $1.5B Yescarta Revenue, 46 FDA-Approved Therapies and $2B Strategic Deals",
        "description": "",
        "summary": "This report provides an in-depth analysis of the Cell and Gene Therapy industry, highlighting key company revenues, regulatory approvals, and market trends. It has been compiled by Towards Healthcare, a sister firm of Precedence Research, offering valuable insights into the latest developments and financials in this rapidly advancing field.Ottawa, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cell and gene therapy (CGT) is rapidly advancing, with major players like Novartis, Gilead, and Bristol Myers Squibb",
        "pubDate": "2026-02-05T13:00:00Z",
        "displayTime": "2026-02-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7",
          "originalWidth": 1667,
          "originalHeight": 1667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2XVm_GDF06LCL8xJEgs9kg--~B/aD0xNjY3O3c9MTY2NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7.cf.webp",
              "width": 1667,
              "height": 1667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ciHBcKYhN1HkkZYm0oIo1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cell-gene-therapy-numbers-1-130000843.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cell-gene-therapy-numbers-1-130000843.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVS"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T12:30:21+00:00",
    "headline": "Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off",
    "summary": "By Michael Erman Feb 5 (Reuters) - Bristol Myers Squibb on Thursday forecast 2026 results above Wall Street estimates, saying that price cuts to its blood thinner Eliquis will help drive up revenue,",
    "url": "https://finance.yahoo.com/news/bristol-myers-forecasts-upbeat-2026-122544598.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "cd30cc79-b136-3169-b28a-29a75faca051",
      "content": {
        "id": "cd30cc79-b136-3169-b28a-29a75faca051",
        "contentType": "STORY",
        "title": "Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off",
        "description": "",
        "summary": "By Michael Erman Feb 5 (Reuters) - Bristol Myers Squibb on Thursday forecast 2026 results above Wall Street estimates, saying that price cuts to its blood thinner Eliquis will help drive up revenue,",
        "pubDate": "2026-02-05T12:30:21Z",
        "displayTime": "2026-02-05T12:30:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/f13d33d6bebf64c8094fff8ae80a91ce",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021.    REUTERS/Brian Snyder",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m_xlhmzHhY1aSUGjS1qOIA--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f13d33d6bebf64c8094fff8ae80a91ce.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TgKEzg9BCh89gV8EeJTIJg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f13d33d6bebf64c8094fff8ae80a91ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-forecasts-upbeat-2026-122544598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-forecasts-upbeat-2026-122544598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T12:09:07+00:00",
    "headline": "Bristol Myers: Q4 Earnings Snapshot",
    "summary": "PRINCETON, N.J. (AP) — Bristol Myers Squibb Co. (BMY) on Thursday reported fourth-quarter net income of $1.09 billion. The Princeton, New Jersey-based company said it had profit of 53 cents per share. Earnings, adjusted for non-recurring costs, came to $1.26 per share.",
    "url": "https://finance.yahoo.com/news/bristol-myers-q4-earnings-snapshot-120907492.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "9791912b-8e8f-33a8-9c79-b70e7078f235",
      "content": {
        "id": "9791912b-8e8f-33a8-9c79-b70e7078f235",
        "contentType": "STORY",
        "title": "Bristol Myers: Q4 Earnings Snapshot",
        "description": "",
        "summary": "PRINCETON, N.J. (AP) — Bristol Myers Squibb Co. (BMY) on Thursday reported fourth-quarter net income of $1.09 billion. The Princeton, New Jersey-based company said it had profit of 53 cents per share. Earnings, adjusted for non-recurring costs, came to $1.26 per share.",
        "pubDate": "2026-02-05T12:09:07Z",
        "displayTime": "2026-02-05T12:09:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-q4-earnings-snapshot-120907492.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-q4-earnings-snapshot-120907492.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T12:09:00+00:00",
    "headline": "Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth",
    "summary": "Bristol Myers Squibb reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for some of its older drugs.",
    "url": "https://www.wsj.com/business/earnings/bristol-myers-squibb-revenue-ticks-up-on-immuno-oncology-growth-8c4bf745?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "15c339cc-1a27-3943-bb09-775568a510fe",
      "content": {
        "id": "15c339cc-1a27-3943-bb09-775568a510fe",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth",
        "description": "",
        "summary": "Bristol Myers Squibb reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for some of its older drugs.",
        "pubDate": "2026-02-05T12:09:00Z",
        "displayTime": "2026-02-05T12:09:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/15c339cc-1a27-3943-bb09-775568a510fe/bristol-myers-squibb-revenue.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/4ab676f7197f892fe88978c84a4ce696",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nIyi47pfBjsNePKZZ85l9Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/4ab676f7197f892fe88978c84a4ce696.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KWem.mH2GvOoeMyi2q6Q7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/4ab676f7197f892fe88978c84a4ce696.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/earnings/bristol-myers-squibb-revenue-ticks-up-on-immuno-oncology-growth-8c4bf745?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T11:59:00+00:00",
    "headline": "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025",
    "summary": "PRINCETON, N.J., February 05, 2026--Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-reports-fourth-115900357.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "15b7b6ba-21d8-37bf-a88d-3c1503ff2aff",
      "content": {
        "id": "15b7b6ba-21d8-37bf-a88d-3c1503ff2aff",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025",
        "description": "",
        "summary": "PRINCETON, N.J., February 05, 2026--Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025",
        "pubDate": "2026-02-05T11:59:00Z",
        "displayTime": "2026-02-05T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/cae83d4626ebdedb8a7927edc5145b6e",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9YmTtgw542cHs6.xMlKOrg--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cae83d4626ebdedb8a7927edc5145b6e.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l__HnsNMm5JRyDXXzouxeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cae83d4626ebdedb8a7927edc5145b6e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-reports-fourth-115900357.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-reports-fourth-115900357.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:51:09+00:00",
    "headline": "Bristol Myers Rises Inside A Buy Zone On Street-Beating 2026 Outlook",
    "summary": "Bristol Myers Squibb stock rose moderately Thursday on better-than-expected fourth-quarter metrics and a strong 2026 outlook.",
    "url": "https://www.investors.com/news/technology/bristol-myers-squibb-stock-bristol-myers-squibb-earnings-q4-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "51aba24a-7d9e-3931-b7ca-00acc74dc972",
      "content": {
        "id": "51aba24a-7d9e-3931-b7ca-00acc74dc972",
        "contentType": "STORY",
        "title": "Bristol Myers Rises Inside A Buy Zone On Street-Beating 2026 Outlook",
        "description": "",
        "summary": "Bristol Myers Squibb stock rose moderately Thursday on better-than-expected fourth-quarter metrics and a strong 2026 outlook.",
        "pubDate": "2026-02-05T13:51:09Z",
        "displayTime": "2026-02-05T13:51:09Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/51aba24a-7d9e-3931-b7ca-00acc74dc972/bristol-myers-rises-inside-a.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722",
          "originalWidth": 1065,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j3JTvymRHXIlwun6knekJg--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722.cf.webp",
              "width": 1065,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w6QlyKN7KTGdJM6jEvgiQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/b3c70d96a5ada9e95a50869c3a4f3722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/bristol-myers-squibb-stock-bristol-myers-squibb-earnings-q4-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:14:27+00:00",
    "headline": "Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025",
    "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q4 CY2025, with sales up 1.4% year on year to $12.5 billion. The company’s full-year revenue guidance of $46.75 billion at the midpoint came in 5.7% above analysts’ estimates. Its non-GAAP profit of $1.26 per share was 4.6% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-nyse-bmy-131427834.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "a9568571-0c1f-33f9-8cbe-7be4ad08eaf6",
      "content": {
        "id": "a9568571-0c1f-33f9-8cbe-7be4ad08eaf6",
        "contentType": "STORY",
        "title": "Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025",
        "description": "",
        "summary": "Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q4 CY2025, with sales up 1.4% year on year to $12.5 billion. The company’s full-year revenue guidance of $46.75 billion at the midpoint came in 5.7% above analysts’ estimates. Its non-GAAP profit of $1.26 per share was 4.6% above analysts’ consensus estimates.",
        "pubDate": "2026-02-05T13:14:27Z",
        "displayTime": "2026-02-05T13:14:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "BMY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gk.7_kJOBQAPS7VxEfLOgw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YM1F85oh4xO4w1Qalh6PGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/37b3541337ce2b08e582bdc742879f1c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-nyse-bmy-131427834.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-nyse-bmy-131427834.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:10:00+00:00",
    "headline": "Bristol Myers Stock Rises. Why Fourth-Quarter Earnings Are Exciting Investors.",
    "summary": "Bristol Myers Squibb  rose Thursday on the back of better-than-expected fourth-quarter earnings but most encouraging was an upbeat outlook from the drugmaker.  Bristol Myers  reported adjusted earnings of $1.26 a share, topping analysts’ consensus of $1.23.  For 2026,  Bristol Myers  sees adjusted earnings in the range of $6.05 to $6.35 a share, above analysts’ forecasts for $6.02.",
    "url": "https://www.barrons.com/articles/bristol-myers-earnings-stock-price-8a5e147c?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "7b757a0e-b906-3bf4-817c-a121d2a115a2",
      "content": {
        "id": "7b757a0e-b906-3bf4-817c-a121d2a115a2",
        "contentType": "STORY",
        "title": "Bristol Myers Stock Rises. Why Fourth-Quarter Earnings Are Exciting Investors.",
        "description": "",
        "summary": "Bristol Myers Squibb  rose Thursday on the back of better-than-expected fourth-quarter earnings but most encouraging was an upbeat outlook from the drugmaker.  Bristol Myers  reported adjusted earnings of $1.26 a share, topping analysts’ consensus of $1.23.  For 2026,  Bristol Myers  sees adjusted earnings in the range of $6.05 to $6.35 a share, above analysts’ forecasts for $6.02.",
        "pubDate": "2026-02-05T13:10:00Z",
        "displayTime": "2026-02-05T13:10:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7b757a0e-b906-3bf4-817c-a121d2a115a2/bristol-myers-stock-rises-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/e6b07ce9d8ca0ecf4229b9a6d0ccd3cb",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0XwUUmjbMNRwdxVgWbM0mw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/e6b07ce9d8ca0ecf4229b9a6d0ccd3cb.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5B1MG36moRtxwhAa9.gZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/e6b07ce9d8ca0ecf4229b9a6d0ccd3cb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/bristol-myers-earnings-stock-price-8a5e147c?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T12:32:00+00:00",
    "headline": "These Stocks Are Today’s Movers: Alphabet, Qualcomm, Broadcom, AMD, Arm, Bristol Myers, Amazon, and More",
    "summary": "Google parent Alphabet beats analysts’ expectations for quarterly earnings and revenue but its capital spending forecasts widely top estimates.",
    "url": "https://www.barrons.com/articles/stock-movers-323f4531?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "f2607ae6-cb53-3ca8-84c2-3e856211fc90",
      "content": {
        "id": "f2607ae6-cb53-3ca8-84c2-3e856211fc90",
        "contentType": "STORY",
        "title": "These Stocks Are Today’s Movers: Alphabet, Qualcomm, Broadcom, AMD, Arm, Bristol Myers, Amazon, and More",
        "description": "",
        "summary": "Google parent Alphabet beats analysts’ expectations for quarterly earnings and revenue but its capital spending forecasts widely top estimates.",
        "pubDate": "2026-02-05T12:32:00Z",
        "displayTime": "2026-02-05T12:32:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f2607ae6-cb53-3ca8-84c2-3e856211fc90/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/7aa4d9501bd368244f0abf912ee9525c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6xG6.vCpOg0xhS.kEIP3aw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/7aa4d9501bd368244f0abf912ee9525c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bcEDRJqTItlnFZFxB_a3jA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/7aa4d9501bd368244f0abf912ee9525c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-323f4531?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AMZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:55:47+00:00",
    "headline": "This Medical Technology Leader Sees Growth Into The 2040s",
    "summary": "Medical technology leader Halozyme Therapeutics is this week's IBD Sector Leaders selection, having bypassed two buy points and entered a buy zone. The recent IBD Stock Of The Day is rallying after the company raised its 2025 and 2026 outlook.",
    "url": "https://www.investors.com/stock-lists/sector-leaders/medical-technology-halozyme-stock-halo-buy-zone-earnings-growth-investing-markets/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "1dc44dac-5a8b-33e4-83cc-b0992cdf9338",
      "content": {
        "id": "1dc44dac-5a8b-33e4-83cc-b0992cdf9338",
        "contentType": "STORY",
        "title": "This Medical Technology Leader Sees Growth Into The 2040s",
        "description": "",
        "summary": "Medical technology leader Halozyme Therapeutics is this week's IBD Sector Leaders selection, having bypassed two buy points and entered a buy zone. The recent IBD Stock Of The Day is rallying after the company raised its 2025 and 2026 outlook.",
        "pubDate": "2026-02-05T14:55:47Z",
        "displayTime": "2026-02-05T14:55:47Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1dc44dac-5a8b-33e4-83cc-b0992cdf9338/this-medical-technology.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4DFBQ9Ovss1qH4kurbDXSw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JlaDjExgRbJnEne6DZDYNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/3240abbfeec5aa04a241f15dd107c385.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/stock-lists/sector-leaders/medical-technology-halozyme-stock-halo-buy-zone-earnings-growth-investing-markets/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HALO"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:45:24+00:00",
    "headline": "Bristol Myers (BMY) Q4 2025 Earnings Transcript",
    "summary": "Chuck Triano: Thank you and good morning everyone.  With me this morning with prepared remarks are Christopher Boerner, our board chair and chief executive officer, and David Elkins, our chief financial officer.  Also participating in today's call is Adam Lenkowsky, our chief commercialization officer, and Cristian Massacesi, our chief medical officer and head of global drug development.",
    "url": "https://www.fool.com/earnings/call-transcripts/2026/02/05/bristol-myers-bmy-q4-2025-earnings-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "66b918c5-acf9-3e53-9f26-16114816c23a",
      "content": {
        "id": "66b918c5-acf9-3e53-9f26-16114816c23a",
        "contentType": "STORY",
        "title": "Bristol Myers (BMY) Q4 2025 Earnings Transcript",
        "description": "",
        "summary": "Chuck Triano: Thank you and good morning everyone.  With me this morning with prepared remarks are Christopher Boerner, our board chair and chief executive officer, and David Elkins, our chief financial officer.  Also participating in today's call is Adam Lenkowsky, our chief commercialization officer, and Cristian Massacesi, our chief medical officer and head of global drug development.",
        "pubDate": "2026-02-05T14:45:24Z",
        "displayTime": "2026-02-05T14:45:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2026/02/05/bristol-myers-bmy-q4-2025-earnings-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-bmy-q4-2025-144524909.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:04:00+00:00",
    "headline": "These Stocks Are Today’s Movers: Alphabet, Strategy, Qualcomm, Broadcom, Estee Lauder, Bristol Myers, Amazon, and More",
    "summary": "Google parent Alphabet beats analysts’ expectations for quarterly earnings and revenue but its capital spending forecasts widely top estimates.",
    "url": "https://www.barrons.com/articles/stock-movers-323f4531?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "f2607ae6-cb53-3ca8-84c2-3e856211fc90",
      "content": {
        "id": "f2607ae6-cb53-3ca8-84c2-3e856211fc90",
        "contentType": "STORY",
        "title": "These Stocks Are Today’s Movers: Alphabet, Strategy, Qualcomm, Broadcom, Estee Lauder, Bristol Myers, Amazon, and More",
        "description": "",
        "summary": "Google parent Alphabet beats analysts’ expectations for quarterly earnings and revenue but its capital spending forecasts widely top estimates.",
        "pubDate": "2026-02-05T14:04:00Z",
        "displayTime": "2026-02-05T14:04:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f2607ae6-cb53-3ca8-84c2-3e856211fc90/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/7aa4d9501bd368244f0abf912ee9525c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6xG6.vCpOg0xhS.kEIP3aw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/7aa4d9501bd368244f0abf912ee9525c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bcEDRJqTItlnFZFxB_a3jA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/7aa4d9501bd368244f0abf912ee9525c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-323f4531?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "EL"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:10:01+00:00",
    "headline": "Bristol Myers Squibb (BMY) Tops Q4 Earnings and Revenue Estimates",
    "summary": "Bristol Myers (BMY) delivered earnings and revenue surprises of +9.33% and +2.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-tops-131001842.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "29be8bfb-a8f0-33c4-9508-54c84683a79b",
      "content": {
        "id": "29be8bfb-a8f0-33c4-9508-54c84683a79b",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb (BMY) Tops Q4 Earnings and Revenue Estimates",
        "description": "",
        "summary": "Bristol Myers (BMY) delivered earnings and revenue surprises of +9.33% and +2.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2026-02-05T13:10:01Z",
        "displayTime": "2026-02-05T13:10:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vqy2StQrekYiw3wwFUCZ6A--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N1J8mAJyPZolYBef44MAwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-tops-131001842.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-tops-131001842.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]